Company News in the Life Science Industry

»

Reset 

China Huadian Supports Indonesia with Anti-Pandemic Supplies in Need

BEIJING, March 26, 2020 /PRNewswire/ -- On March 24, a batch of medical protective materials worth around 1.25 million yuan has departed from Shanghai Pudong International Airport for Soekarno-Hatta International Airport in Jakarta, Indonesia. This is the first round of overseas anti-pandemic... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Nippon Express Receives GDP Certification for Temperature-controlled Facility in Narita Area

TOKYO, March 26, 2020 /PRNewswire/ -- Nippon Express Co., Ltd., has received Good Distribution Practice (GDP) certification indicating compliance with industry-accepted standards for the proper distribution of pharmaceutical products for its in-transit air cargo storage services at the Narita... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Breaking the Contagious Chain of COVID-19 - Farmaku Hands Out 10,000 Free Skrineer Masks for Indonesian Medical Workers

JAKARTA, Indonesia, March 26, 2020 /PRNewswire/ -- With the Coronavirus (COVID-19) outbreak increasing in numbers in the Jabodetabek area, mask prices have become extremely high due to demand. Farmaku.com as a startup operating in the pharmaceutical and apothecary space have moved to... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

CStone Pharmaceuticals Reports 2019 Annual Financial Results

SHANGHAI, March 26, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology (IO) therapies and molecularly-targeted precision medicines for the treatment of cancer, today released... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  CStone Pharmaceuticals

Oncopeptides Announces 26% Overall Response Rate of Melflufen in Triple-class Refractory Multiple Myeloma Patients From the Pivotal HORIZON Study

STOCKHOLM, March 26, 2020 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO)

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Oncopeptides AB

Mylan and Pfizer Provide Update Regarding Proposed Combination of Mylan and Upjohn

HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, March 26, 2020 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced that due to the unprecedented circumstances surrounding the COVID-19 pandemic, including associated delays in the regulatory review process,... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Regarding HLCM051 for Acute Respiratory Distress Syndrome (ARDS) Caused by COVID -19

TOKYO, March 26, 2020 /PRNewswire/ -- HEALIOS K.K. ("Healios") is developing new treatments for Acute Respiratory Distress Syndrome (ARDS)(1) and Ischemic Stroke in Japan using the stem cell product HLCM051 (MultiStem®). Healios continues to make enrolment progress in its Phase 2 clinical study... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020

Medical Nonwoven Disposables Play Crucial Role in Preventing Spread of COVID-19 Across Countries; Continuing Demand Propel Growth, Observes TMR

- Extensive adoption of all types of medical nonwoven disposables by healthcare staff to prevent infectious diseases key to growth

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Transparency Market Research

Selvita 2019 Financial Results: Accelerated Growth, 43 Percent Increase in Commercial Revenues and a Very Solid Backlog for 2020

KRAKOW, Poland, March 26, 2020 /PRNewswire/ -- Selvita S.A. (WSE: SLV) - one of the largest preclinical contract research organizations in Europe - reported today its annual financial results for 2019 and provided a corporate update.

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Selvita Inc.

RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress

ZURICH, March 26, 2020 /PRNewswire/ -- RELIEF THERAPEUTICS Holding AG (SIX: RLF) "Relief", together with NeuroRx, a Delaware Corporation, have filed an Investigational New Drug (IND) Application with the US FDA for a phase 2 trial of RLF-100 (Aviptadil) in the treatment of Acute and... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  NeuroRx, Inc.

Castor Launches COVID-19 Monitoring and Research Platform and is Supporting Over 50 Trials Globally

- Platform to facilitate rapid deployment of trials to test vaccines and treatments

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020

First Stop Health Telemedicine Demand Up 92% as Doctors Respond to Patients Within 15 Minutes During COVID-19 Pandemic

CHICAGO, March 26, 2020 /PRNewswire/ -- Telemedicine demand has reached an unprecedented high as people are told to stay home and avoid places with ill people. First Stop Health is helping keep its clients' patients away from medical waiting rooms with 24/7 access to doctors within 15 minutes,... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  First Stop Health

SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia

FOSTER CITY, Calif., March 26, 2020 /PRNewswire/ -- SutroVax, a biopharmaceutical company dedicated to the delivery of superior and novel vaccines... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Sutro Biopharma, Inc.

Apexigen To Present At The Upcoming 2020 Solebury Trout Virtual Investor Conference

SAN CARLOS, Calif., March 26, 2020 /PRNewswire/ -- Apexigen, Inc., a clinical-stage biopharmaceutical company, today announced that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, plans to present an overview of the company at the upcoming Solebury Trout Virtual Investor Conference.... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Apexigen, Inc

Butterfly Network Names Laurent Faracci as Chief Executive Officer

GUILFORD, Conn., March 26, 2020 /PRNewswire/ -- Butterfly Network, the company helping to transform healthcare with its disruptive, ultrasound-on-chip(TM) technology, has named Laurent Faracci as CEO.

Read more ››
By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Butterfly Network, Inc

Biocartis Announces Co-Commercialization of the SeptiCyte® RAPID Test on Idylla™ (CE-IVD) and Provides Update on COVID-19 Impact

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Biocartis NV

IBA Reports Full Year 2019 Results

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Ion Beam Applications S.A. (IBA)

Bone Therapeutics appoints Stefanos Theoharis as Chief Business Officer

Read more ››
By: GlobenewsWire - 26 Mar 2020
Related companies:  Bone Therapeutics SA

Innovent Biologics Enters into a Collaboration with Alector to Develop and Commercialize Anti-SIRP-alpha Antibody in China

SUZHOU, China, March 26, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, and... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
Related companies:  Innovent Biologics Co., Ltd.

XABT donates 2019-nCoV nucleic acid detection kits to Italy

BEIJING, March 25, 2020 /PRNewswire/ -- On March 19, the 2019-nCoV Detection Kit and Nucleic Acid Extraction Donation & Shipment Ceremony was held in Beijing. Beijing Applied Biological Technologies Co., Ltd. (XABT) was invited to the event at which the biologics maker donated an allotment... Read more ››

By: PR Newswire Association LLC. - 26 Mar 2020
«  1  2  3  4  5  6  7  8  9  10  11 12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies